(168 days)
Not Found
No
The document describes image processing software with standard radiology functions. There is no mention of AI, machine learning, or neural networks.
No.
The device is an image processing software for display and processing of medical images, which is not considered a therapeutic device. It does not perform any therapeutic function.
Yes
The device is image processing software for XA, CT, and MR images, and its description explicitly states it can be deployed as a "stand-alone diagnostic review and post processing workstation," indicating its intended use in diagnostic processes.
Yes
The description explicitly states the device is "image processing software" and detailing its functions related to processing and displaying medical images from various modalities. While it can be deployed on hardware, the device itself is software.
No
The device processes existing medical images (XA, CT, MR) for display and analysis, which falls under medical image processing software, not IVD which analyzes biological samples.
N/A
Intended Use / Indications for Use
uWS-Angio Basic is intended to display and process XA (X-Ray Angiographic), CT (Computed Tomography), and MR (Magnetic Resonance) images that comply with the DICOM3.0 protocol.
Product codes
LLZ
Device Description
uWS-Angio Basic is an image processing software that matches the use of medical vascular angiography X-ray machines. It contains the following functions:
- Patient Administration
- Review 2D: This application can be used to load 2D images and perform related processing. The function provides Basic processing tools for
- 2D image viewing,
- 2D image processing,
- 2D DSA image viewing and processing,
- Calibration and Measurement.
- Review 3D: This application can be used for loading and processing 3D data. The function provides Basic processing tools for
- 3D image viewing;
- 3D image processing;
- CTA bone removal.
- Saving
- Filming
uWS-Angio Basic can be deployed on independent hardware such as a stand-alone diagnostic review and post processing workstation. It can also be configured within a network to send and receive DICOM data. Furthermore, it can be deployed on systems of the United-imaging Angiography system family.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
XA (X-Ray Angiographic), CT (Computed Tomography), and MR (Magnetic Resonance) images that comply with the DICOM3.0 protocol.
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare professionals in healthcare institution settings.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Software verification and validation testing was provided to demonstrate safety and efficacy of the proposed device. This includes a hazard analysis, and the potential hazards to satisfy the recommended documentation for basic documentation. These documentations include:
- Software Description
- Device Hazard Analysis
- Software Requirements Specification (SRS)
- Software Architecture Design Chart
- Software Development Environment Description
- Software Verification and Validation
- Cybersecurity Documents
The algorithms involved in the uWS-Angio Basic are as follows:
- Catheter Calibration Algorithm for Review 2D
- CTA Removing Bone Algorithm for Review 3D
Testing was conducted between uWS-Angio Basic and the predicate device to evaluate the performance of the algorithms mentioned above. It is shown that catheter calibration of uWS-Angio Basic has high accuracy with average error rates consistently lower than those of the predicate device. CTA Removing Bone of the uWS-Angio Basic perform as well as the predicate devices.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
FDA 510(k) Clearance Letter - uWS-Angio Basic
Page 1
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
May 12, 2025
Shanghai United Imaging Healthcare Co., Ltd.
℅ Xin Gao
RA Manager
No. 2258 Chengbei Rd. Jiading District
SHANGHAI, 201807
CHINA
Re: K243632
Trade/Device Name: uWS-Angio Basic
Regulation Number: 21 CFR 892.2050
Regulation Name: Medical Image Management And Processing System
Regulatory Class: Class II
Product Code: LLZ
Dated: April 11, 2025
Received: April 11, 2025
Dear Xin Gao:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Page 2
K243632 - Xin Gao Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
Page 3
K243632 - Xin Gao Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Lu Jiang
Lu Jiang, Ph.D.
Assistant Director
Diagnostic X-Ray Systems Team
DHT8B: Division of Radiological Imaging
Devices and Electronic Products
OHT8: Office of Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
Page 4
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
510(k) Number (if known)
K243632
Device Name
uWS-Angio Basic
Indications for Use (Describe)
uWS-Angio Basic is intended to display and process XA (X-Ray Angiographic), CT (Computed Tomography), and MR (Magnetic Resonance) images that comply with the DICOM3.0 protocol.
Type of Use (Select one or both, as applicable)
☒ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 5
510 (k) SUMMARY
1. Date of Preparation:
May 7, 2025
2. Sponsor Identification
Shanghai United Imaging Healthcare Co.,Ltd.
No.2258 Chengbei Rd. Jiading District, 201807, Shanghai, China
Establishment Registration Number: 3011015597
Contact Person: Xin GAO
Position: Regulatory Affairs Specialist
Tel: +86-021-67076888-5386
Fax: +86-021-67076889
Email: xin.gao@united-imaging.com
3. Identification of Proposed Device
Trade Name: uWS-Angio Basic
Common Name: Medical image management and processing system
Model(s): uWS-Angio Basic
Regulatory Information
Classification Name: Medical image management and processing system
Classification: II
Product Code: LLZ
Regulation Number: 21 CFR 892.2050
Review Panel: Radiology
4. Identification of Predicate Device(s)
Predicate Device
510(k) Number: K230955
Device Name: Syngo Application Software
Secondary Predicate Device#1
510(k) Number: K183170
Page 6
Device Name: uWS-CT
Secondary Predicate Device#2
510(k) Number: K232147
Device Name: CAAS Workstation
5. Device Description
uWS-Angio Basic is an image processing software that matches the use of medical vascular angiography X-ray machines. It contains the following functions:
- Patient Administration
- Review 2D: This application can be used to load 2D images and perform related processing. The function provides Basic processing tools for
- 2D image viewing,
- 2D image processing,
- 2D DSA image viewing and processing,
- Calibration and Measurement.
- Review 3D: This application can be used for loading and processing 3D data. The function provides Basic processing tools for
- 3D image viewing;
- 3D image processing;
- CTA bone removal.
- Saving
- Filming
uWS-Angio Basic can be deployed on independent hardware such as a stand-alone diagnostic review and post processing workstation. It can also be configured within a network to send and receive DICOM data. Furthermore, it can be deployed on systems of the United-imaging Angiography system family.
6. Indications for use
uWS-Angio Basic is intended to display and process XA (X-Ray Angiographic), CT (Computed Tomography), and MR (Magnetic Resonance) images that comply with the DICOM3.0 protocol.
7. Summary of Technological Characteristics
Page 7
The proposed device uWS-Angio Basic and the predicate device syngo Application Software share similar indications for use: enabling the viewing and post-processing of medical images from angiography systems and other DICOM data through basic functions. Both devices are indicated for patients undergoing angiography and fluoroscopy-based procedures and are designed to support healthcare professionals in healthcare institution settings. The intended patient population and applicable clinical scenarios are the same for these two devices. The proposed device includes fewer applications compared to the predicate device. The difference does not raise different questions of safety and effectiveness
The following tables present a comparative analysis of the main features, principles of operation, fundamental scientific technology and intended use of the proposed device in relation to both predicate device and Secondary predicate devices.
Page 8
Table 1 General information comparison
| Item | Proposed Device uWS-Angio Basic | Predicate Device syngo Application Software (K230955) | Remark |
|---|---|---|---|
| General | |||
| Device Classification Name | Medical Image Management and Processing System | Medical Image Management and Processing System | Same |
| Product Code | LLZ | LLZ | Same |
| Regulation Number | 21 CFR 892.2050 | 21 CFR 892.2050 | Same |
| Device Class | II | II | Same |
| Classification Panel | Radiology | Radiology | Same |
Page 9
Table 2 Substantial equivalence discussion for uWS-Angio Basic functions
| Item | Function name | Proposed device uWS-Angio Basic | Predicate device Syngo Application Software (K230955) | Secondary predicate device#1: uWS-CT (K183170) | Secondary predicate device#2: CAAS Workstation (K232147) | Remark |
|---|---|---|---|---|---|---|
| Patient Administration | Patient data display | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) |
| Searching, filtering, importing, archiving and modification of patient data | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| 2D image viewing | ||||||
| Data loading and displaying | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| 2D image processing | ||||||
| Review 2D | Invert | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) |
| Shutter | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Zoom/pan | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Windowing | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Flip | Yes | Yes | Yes | / | Same (Identical with uWS-CT) |
Page 10
| Annotation | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
|---|---|---|---|---|---|---|
| Enhance Edge | Yes | Yes | / | / | Same | |
| Synchronize series | Yes | / | / | / | Note1 | |
| Reset & Undo | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Crop series | Yes | / | / | / | Note 2 | |
| 2D DSA image viewing and processing | ||||||
| Sub/unsub | Yes | Yes | / | Yes | Same | |
| Pixel shift | Yes | Yes | / | / | Same | |
| Anatomical background adjustment | Yes | Yes | / | / | Same | |
| Moving Mask | Yes | Yes | / | / | Same | |
| Maximum filled | Yes | Yes | / | Yes | Same | |
| Calibration | ||||||
| Isocenter calibration | Yes | Yes | / | Yes | Same | |
| Catheter calibration | Yes | Yes | / | Yes | Same | |
| Manual distance calibration | Yes | Yes | / | Yes | Same | |
| Sphere calibration | Yes | Yes | / | Yes | Same | |
| Measurement | ||||||
| Distance measurement | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Curve measurement | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Angle measurement | Yes | Yes | Yes | Yes | Same (Identical with uWS-CT) | |
| Ratio Calculation | Yes | / | / | Yes | Same | |
| 3D image viewing | ||||||
| Review 3D | Support volume rending (VR) and MPR image display | Yes | Yes | Yes | / | Same (Identical with uWS-CT) |
Page 11
| Switching display layout | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
|---|---|---|---|---|---|---|
| 3D image processing | ||||||
| Zoom | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Pan | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Windowing | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Thickness adjustment | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Rotate | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Annotation | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| 3D calculation | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| Cut | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| VOI extraction | Yes | Yes | Yes | / | Same (Identical with uWS-CT) | |
| CTA bone removal | Yes | / | Yes | / | Same (Identical with uWS-CT) | |
| Saving | Image/movie/bookmark saving | Yes | Yes | Yes | / | Same (Identical with uWS-CT) |
| Filming | Layout editing and printing | Yes | / | Yes | / | Same (Identical with uWS-CT) |
Page 12
Note 1: Compared to the predicate device and Secondary predicate devices, the proposed device adds Synchronize Series function. This function can synchronize double series, compare and view two series. This difference does not raise different questions of safety and effectiveness.
Note 2: Compared to the predicate device and Secondary predicate devices, the proposed device adds Crop Series function. This function can help user to eliminate unwanted images from a series. This difference does not raise different questions of safety and effectiveness.
Page 13
8. Performance Data
The following performance data were provided in support of the substantial equivalence determination.
Biocompatibility
Not Applicable to the proposed device, because the device is stand-alone software.
Electrical Safety and Electromagnetic Compatibility (EMC)
Not Applicable to the proposed device, because the device is stand-alone software.
Software
Software verification and validation testing was provided to demonstrate safety and efficacy of the proposed device. This includes a hazard analysis, and the potential hazards to satisfy the recommended documentation for basic documentation. These documentations include:
- Software Description
- Device Hazard Analysis
- Software Requirements Specification (SRS)
- Software Architecture Design Chart
- Software Development Environment Description
- Software Verification and Validation
- Cybersecurity Documents
Animal Study
No animal study was required.
Clinical Studies
No clinical study was required.
Performance Testing
The algorithms involved in the uWS-Angio Basic are as follows:
- Catheter Calibration Algorithm for Review 2D
- CTA Removing Bone Algorithm for Review 3D
Testing was conducted between uWS-Angio Basic and the predicate device to evaluate the performance of the algorithms mentioned above. It is shown that catheter calibration of uWS-Angio Basic has high accuracy with average error rates consistently lower than those of the predicate device. CTA Removing Bone of the uWS-Angio Basic perform as well as the predicate devices.
Page 14
Other Standards
- NEMA PS 3.1 - 3.20 Digital Imaging and Communications in Medicine (DICOM) Set (2023e).
- ISO 14971 Medical devices - Application of risk management to medical devices (Third Edition 2019-12).
- IEC 62304 Medical device software - Software life cycle processes (Edition 1.1, 2015).
Summary
The features described in this premarket submission are supported with the results of the testing mentioned above; the uWS-Angio Basic is found to have a safety and effectiveness profile that is similar to the predicate device and Secondary predicate devices.
9. Substantially Equivalent (SE) Conclusion
The proposed device is substantially equivalent to the predicate device. This conclusion is based upon a comparison of intended use, technological characteristics, performance specification, device hazards as well as verification and validation results.